Asia Pacific Onychomycosis Market Size, Growth Report to 2028

Asia Pacific Onychomycosis Market Size, Share & Industry Trends Analysis Report By Type (Distal Subungual, Proximal Subungual, White Superficial and Others), By Treatment (Topical, Oral and Others), By Country and Growth Forecast, 2022 - 2028

Published Date: February-2023 | Number of Pages: 79 | Format: PDF | Report ID: KBV-14159

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Onychomycosis Market, by Type
1.4.2 Asia Pacific Onychomycosis Market, by Treatment
1.4.3 Asia Pacific Onychomycosis Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Onychomycosis Market by Type
3.1 Asia Pacific Distal Subungual Market by Country
3.2 Asia Pacific Proximal Subungual Market by Country
3.3 Asia Pacific White Superficial Market by Country
3.4 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Onychomycosis Market by Treatment
4.1 Asia Pacific Topical Market by Country
4.2 Asia Pacific Oral Market by Country
4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Onychomycosis Market by Country
5.1 China Onychomycosis Market
5.1.1 China Onychomycosis Market by Type
5.1.2 China Onychomycosis Market by Treatment
5.2 Japan Onychomycosis Market
5.2.1 Japan Onychomycosis Market by Type
5.2.2 Japan Onychomycosis Market by Treatment
5.3 India Onychomycosis Market
5.3.1 India Onychomycosis Market by Type
5.3.2 India Onychomycosis Market by Treatment
5.4 Australia Onychomycosis Market
5.4.1 Australia Onychomycosis Market by Type
5.4.2 Australia Onychomycosis Market by Treatment
5.5 South Korea Onychomycosis Market
5.5.1 South Korea Onychomycosis Market by Type
5.5.2 South Korea Onychomycosis Market by Treatment
5.6 Singapore Onychomycosis Market
5.6.1 Singapore Onychomycosis Market by Type
5.6.2 Singapore Onychomycosis Market by Treatment
5.7 Rest of Asia Pacific Onychomycosis Market
5.7.1 Rest of Asia Pacific Onychomycosis Market by Type
5.7.2 Rest of Asia Pacific Onychomycosis Market by Treatment

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Bausch Health Companies, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Trials and Approvals:
6.3 Bayer AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Expansions:
6.4 Cipla Limited
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 Sun Pharmaceutical Industries Ltd.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.6 GlaxoSmithKline PLC (GSK)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional & Segmental Analysis
6.7.4 Research & Development Expense
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.9 Merck & Co., Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.10. Novartis AG
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expense

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities